BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18497723)

  • 1. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic syndrome and lipotoxicity].
    Shimabukuro M
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1721-5. PubMed ID: 17037305
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance as the underlying cause for the metabolic syndrome.
    Lann D; LeRoith D
    Med Clin North Am; 2007 Nov; 91(6):1063-77, viii. PubMed ID: 17964909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic consequences of hyperglycemia and insulin resistance.
    Jellinger PS
    Clin Cornerstone; 2007; 8 Suppl 7():S30-42. PubMed ID: 18154189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment of metabolic syndrome.
    Altabas V
    Curr Clin Pharmacol; 2013 Aug; 8(3):224-31. PubMed ID: 22950955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome: insulin resistance.
    Mikhail N
    Curr Hypertens Rep; 2009 Apr; 11(2):156-8. PubMed ID: 19278606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The link between abdominal obesity and the metabolic syndrome.
    Phillips LK; Prins JB
    Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
    Robinson LE; Graham TE
    Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiftwork and higher pancreatic secretion: early detection of an intermediate state of insulin resistance?
    Esquirol Y; Bongard V; Ferrieres J; Verdier H; Perret B
    Chronobiol Int; 2012 Nov; 29(9):1258-66. PubMed ID: 23005602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of the metabolic syndrome.
    McCracken E; Monaghan M; Sreenivasan S
    Clin Dermatol; 2018; 36(1):14-20. PubMed ID: 29241747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of vitamin D and metabolic syndrome: A review.
    Prasad P; Kochhar A
    Diabetes Metab Syndr; 2016; 10(2):105-12. PubMed ID: 25813139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dysmetabolic syndrome: epidemiology and etiology.
    Sauerwein HP
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
    Borgman M; McErlean E
    J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?
    Meas T
    Diabetes Metab; 2010 Feb; 36(1):11-20. PubMed ID: 19815442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome: therapeutic considerations.
    Grundy SM
    Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes.
    Prentki M; Madiraju SR
    Mol Cell Endocrinol; 2012 Apr; 353(1-2):88-100. PubMed ID: 22108437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.